loading

Satellos Bioscience Inc (MSLE) 最新ニュース

pulisher
Apr 12, 2026

MSLE : Satellos Bioscience Inc. Key Company Metrics & Non-finance Metrics - Zacks Investment Research

Apr 12, 2026
pulisher
Apr 12, 2026

MSLE: Satellos Bioscience Inc.Insider Transations - Zacks Investment Research

Apr 12, 2026
pulisher
Apr 09, 2026

Satellos to Present at the Bloom Burton & Co. Healthcare Investor Conference - Investing News Network

Apr 09, 2026
pulisher
Apr 09, 2026

Satellos Bioscience to Showcase DMD Program at April Bloom Burton Healthcare Investor Conference - TipRanks

Apr 09, 2026
pulisher
Apr 09, 2026

Satellos Bioscience (NASDAQ: MSLE) plans Bloom Burton investor conference presentation - Stock Titan

Apr 09, 2026
pulisher
Apr 07, 2026

Satellos Bioscience (NASDAQ:MSLE) Coverage Initiated by Analysts at Leerink Partners - Defense World

Apr 07, 2026
pulisher
Apr 06, 2026

Satellos Bioscience Inc. (NASDAQ:MSLE) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat

Apr 06, 2026
pulisher
Apr 06, 2026

Satellos Bioscience (NASDAQ:MSLE) Now Covered by Analysts at Leerink Partners - MarketBeat

Apr 06, 2026
pulisher
Apr 06, 2026

Leerink initiates Satellos Bioscience stock with Outperform rating By Investing.com - Investing.com South Africa

Apr 06, 2026
pulisher
Apr 06, 2026

MSLE Archives - 24/7 Wall St.

Apr 06, 2026
pulisher
Apr 06, 2026

Leerink initiates Satellos Bioscience stock with Outperform rating - Investing.com

Apr 06, 2026
pulisher
Apr 06, 2026

Satellos initiated with an Outperform at Leerink - TipRanks

Apr 06, 2026
pulisher
Apr 06, 2026

Investment bank Leerink Partners recently released a research report, initiating coverage on biotechnology company Satellos Bioscience Inc. (stock symbol: MSLE) for the first time. - Bitget

Apr 06, 2026
pulisher
Apr 03, 2026

Satellos Bioscience Inc. (0IT.SG) Options Chain - Yahoo! Finance Canada

Apr 03, 2026
pulisher
Apr 03, 2026

All News for MSLE : Satellos Bioscience Inc. - Zacks Investment Research

Apr 03, 2026
pulisher
Apr 02, 2026

What date does Satellos Bioscience Inc.'s (MSLE) report EarningsEarnings Calendar & Announcement - zacks.com

Apr 02, 2026
pulisher
Apr 01, 2026

Long Term Trading Analysis for (MSCL) (MSCL:CA) - Stock Traders Daily

Apr 01, 2026
pulisher
Apr 01, 2026

Brokers Offer Predictions for MSLE FY2030 Earnings - Defense World

Apr 01, 2026
pulisher
Mar 31, 2026

FY2030 Earnings Forecast for MSLE Issued By HC Wainwright - MarketBeat

Mar 31, 2026
pulisher
Mar 31, 2026

Dividend HistorySatellos Bioscience Inc. (MSLE) - Zacks Investment Research

Mar 31, 2026
pulisher
Mar 30, 2026

Satellos Bioscience: 2025 Financial Performance - AlphaStreet

Mar 30, 2026
pulisher
Mar 28, 2026

Satellos Bioscience (NASDAQ:MSLE) Releases Earnings Results - MarketBeat

Mar 28, 2026
pulisher
Mar 27, 2026

Stocks in play: Satellos Bioscience Inc. - Barchart

Mar 27, 2026
pulisher
Mar 27, 2026

Satellos Bioscience Posts 2025 Results, Advances SAT-3247 Into Global Phase 2 Duchenne Trials - TipRanks

Mar 27, 2026
pulisher
Mar 27, 2026

Satellos Bioscience Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com

Mar 27, 2026
pulisher
Mar 27, 2026

Satellos Bioscience: Q4 Earnings Snapshot - marketscreener.com

Mar 27, 2026
pulisher
Mar 27, 2026

Satellos Bioscience : Fourth Quarter 2025 Management’s Discussion Analysis - marketscreener.com

Mar 27, 2026
pulisher
Mar 27, 2026

Satellos Bioscience (NASDAQ: MSLE) files annual report; 15,458,903 shares - Stock Titan

Mar 27, 2026
pulisher
Mar 27, 2026

Satellos Bioscience (MSLE) funds 2027 runway while advancing Phase 2 DMD trials - Stock Titan

Mar 27, 2026
pulisher
Mar 27, 2026

Satellos Reports 2025 Financial Results and Highlights Recent Company Progress - 富途牛牛

Mar 27, 2026
pulisher
Mar 23, 2026

MSLE Earnings History & Surprises | EPS & Revenue Results | SATELLOS BIOSCIENCE INC (NASDAQ:MSLE) - ChartMill

Mar 23, 2026
pulisher
Mar 23, 2026

MSLE News | SATELLOS BIOSCIENCE INC (NASDAQ:MSLE) - ChartMill

Mar 23, 2026
pulisher
Mar 18, 2026

12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga

Mar 18, 2026
pulisher
Mar 14, 2026

Satellos Bioscience (NASDAQ:MSLE) Downgraded to "Strong Sell" Rating by Wall Street Zen - MarketBeat

Mar 14, 2026
pulisher
Mar 13, 2026

Cantor Fitzgerald Initiates Coverage on Satellos Bioscience (NASDAQ:MSLE) - Defense World

Mar 13, 2026
pulisher
Mar 12, 2026

(MSCL) Comprehensive Trading Strategy Report (MSCL:CA) - Stock Traders Daily

Mar 12, 2026
pulisher
Mar 12, 2026

This Canadian biotech stock will beat the market, analyst says - Cantech Letter

Mar 12, 2026
pulisher
Mar 11, 2026

This Ligand Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Wednesday - Benzinga

Mar 11, 2026
pulisher
Mar 10, 2026

Satellos Bioscience Inc. - Mena FN

Mar 10, 2026
pulisher
Mar 10, 2026

Satellos Presents Interim SAT-3247 Clinical and Biomarker Data in Duchenne Muscular Dystrophy at the 2026 MDA Clinical & Scientific Conference - Bitget

Mar 10, 2026
pulisher
Mar 10, 2026

Satellos Bioscience Unveils Positive Interim SAT-3247 Data in Duchenne Muscular Dystrophy at MDA 2026 - TipRanks

Mar 10, 2026
pulisher
Mar 10, 2026

Interim Duchenne and FSHD data on SAT-3247 from Satellos (NASDAQ: MSLE) - Stock Titan

Mar 10, 2026
pulisher
Mar 09, 2026

(MSCL) Advanced Equity Analysis (MSCL:CA) - Stock Traders Daily

Mar 09, 2026
pulisher
Mar 07, 2026

Satellos prices $50M public offering - MSN

Mar 07, 2026
pulisher
Mar 06, 2026

(MSCL) Technical Analysis and Trading Signals (MSCL:CA) - Stock Traders Daily

Mar 06, 2026
pulisher
Mar 06, 2026

Satellos Bioscience Inc expected to post a loss of 21 cents a shareEarnings Preview - TradingView

Mar 06, 2026
pulisher
Mar 04, 2026

(MSCL) Trading Performance and Risk Management (MSCL:CA) - Stock Traders Daily

Mar 04, 2026
pulisher
Feb 27, 2026

MSCLFSatellos Bioscience Inc Latest Stock News & Market Updates - Stock Titan

Feb 27, 2026
pulisher
Feb 26, 2026

(MSCL) Strategic Market Analysis (MSCL:CA) - Stock Traders Daily

Feb 26, 2026
pulisher
Feb 26, 2026

Satellos Bioscience (MSLE) Stock Analysis Report | Financials & Insights - Benzinga España

Feb 26, 2026
pulisher
Feb 24, 2026

Duchenne Muscular Dystrophy Clinical Trial Pipeline Gains Momentum: 75+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight - StreetInsider

Feb 24, 2026
pulisher
Feb 24, 2026

Satellos Announces Upcoming Oral and Poster Presentations at the 2026 Muscular Dystrophy Association Clinical & Scientific Conference - BioSpace

Feb 24, 2026
$53.24
price down icon 1.77%
$48.57
price down icon 0.02%
$99.29
price down icon 0.06%
$155.58
price up icon 1.87%
$143.53
price down icon 2.22%
ONC ONC
$320.76
price up icon 0.38%
大文字化:     |  ボリューム (24 時間):